Rekod bukti kaedah

Adaptive Phase IV study

An Adaptive Phase IV study is a post-marketing surveillance study conducted after a drug or intervention has received regulatory approval, augmented with pre-specified adaptive design elements that allow pre-planned modifications to the study protocol in response to accumulating data. These modifications may include sample size re-estimation, endpoint adjustments, or population enrichment, all governed by statistical rules set before the study begins, preserving scientific integrity while increasing efficiency.

Sources recorded, not reviewed

Rekod sumber

Petikan disalin secara verbatim daripada rekod sumber kaedah. Tiada pengesahan peringkat tuntutan disimpulkan daripadanya.

Adaptive Phase IV Post-Marketing Study

Rekod kaedah taksonomik · process-pipeline / epidemiology

Chow, S. C., & Chang, M. (2008). Adaptive Design Methods in Clinical Trials. Chapman and Hall/CRC. · ISBN 978-1584889625
U.S. Food and Drug Administration. (2019). Adaptive Designs for Clinical Trials of Drugs and Biologics: Guidance for Industry. FDA. · URL

Buka kaedah penuh

Tuntutan yang dikurasi

Tuntutan disimpan dalam lejar bukti, setiap satu dengan penilaiannya sendiri.

Tiada tuntutan terkurasi lagi

Pandangan ini tidak mencipta penilaian tuntutan apabila lejar tiada.

Kaedah berkaitan

Dijana daripada graf kaedah dan ditunjukkan sebagai perhubungan yang dicadangkan mesin — tiada tuntutan bukti disimpulkan.

Taxonomic bucketAdaptive Phase III clinical trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketAdaptive Randomized Clinical Trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketBayesian Phase IV studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketCohort Studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPhase IV studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPragmatic phase IV studymachine-suggested · Relational suggestion, not evidence.